Climb Bio, Inc. (CLYM)
NASDAQ: CLYM · Real-Time Price · USD
2.230
0.00 (0.00%)
Sep 2, 2025, 10:32 AM - Market open

Climb Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2020
1511217498278-
Upgrade
Market Cap Growth
-60.39%62.54%-23.65%-64.90%--
Upgrade
Enterprise Value
-38-97-33-32108-
Upgrade
Last Close Price
2.231.802.703.6710.46-
Upgrade
PB Ratio
0.810.570.690.761.66-
Upgrade
P/TBV Ratio
0.800.570.690.761.66-
Upgrade
Debt / Equity Ratio
0.000.000.000.00--
Upgrade
Quick Ratio
13.6530.8338.5721.3523.798.16
Upgrade
Current Ratio
14.0831.4138.9222.0424.588.76
Upgrade
Return on Equity (ROE)
-22.92%-46.26%-29.72%-30.58%-50.16%-96.73%
Upgrade
Return on Assets (ROA)
-15.83%-10.30%-10.93%-18.30%-22.54%-31.96%
Upgrade
Return on Capital (ROIC)
-16.20%-10.54%-11.31%-19.04%-23.55%-34.42%
Upgrade
Earnings Yield
-31.36%-61.07%-47.17%-46.40%-17.09%-
Upgrade
Buyback Yield / Dilution
-139.53%-78.47%-2.57%-114.60%-460.40%-31.72%
Upgrade
Updated Aug 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q